With MAKO Surgical shares having taken a hit recently after a couple instances of lowering guidance, Motley Fool health care bureau chief Brenton Flynn took a look in a recent video at 2 key statistics to watch ahead of MAKO's third quarter earnings release: How many new sales of its robotic surgical systems did it make to hospitals this quarter, and how many procedures per month did these systems perform once they were installed? Now that the earnings have come out, Flynn breaks down his benchmarks for how the company needed to perform in these two vital areas, how it surpassed his expectations in one regard, and why he's still cautiously optimistic.
The recent market sell-off of MAKO Surgical shares has many wondering whether the potential growth prospects of the robotic surgery company make this stock a buy or a stock to stay away from. To answer this question, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading. .